The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Werner Milton H. since 2021.
This trader's CIK number is 1827621.
At the time of last reporting, Werner Milton H. was the President and CEO of Inhibikase Therapeutics, Inc.. (stock ticker symbol IKT).
Also see all insider trading activities at Inhibikase Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | IKT | 20,000 | $14,880 | 0 | $0 | 21,853 | $44,143 |
| 2021 | IKT | 23,589 | $46,140 | 0 | $0 | 21,853 | $44,143 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-08-16 | IKT | Buy | 5,000 | .80 | 4,000 |
| 2022-05-27 | IKT | Buy | 5,000 | .98 | 4,880 |
| 2022-05-20 | IKT | Buy | 10,000 | .60 | 6,000 |
| 2022-01-03 | IKT | Option Ex | 21,853 | 2.02 | 44,143 |
| 2021-11-17 | IKT | Buy | 23,589 | 1.96 | 46,140 |
| 2021-08-17 | IKT | Option Ex | 21,853 | 2.02 | 44,143 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Werner Milton H. (President and CEO of Inhibikase Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.